Abstract: The invention relates to a motor housing for an electric motor with a stator as well as to an electric motor with a housing, whereby at least one multifunctional opening is arranged in the lower housing section and whereby electronics can be arranged in the housing, characterized in that, in order to cool the electronics, the multifunctional opening has a baffle by means of which an air flow can be directed towards the electronics, and, as an alternative, it has an offset on the side facing the upper housing section in order to mechanically connect the stator to the lower housing section.

Abstract: An aircraft fuselage includes at least one space arranged in the aircraft fuselage and at least one wall. The wall resists burnthrough for a period of at least four minutes from outside the aircraft fuselage towards the space, wherein the region of the aircraft fuselage underneath the space does not include burnthrough-resistant insulation. The space may be a cargo compartment of the aircraft or a passenger cabin, while the wall may be designed as a cargo compartment floor, passenger cabin floor or wing/fuselage fairing (belly fairing). The design of the aircraft fuselage results in burnthrough resistance that meets the requirements of FAR §25.856 (b) without any additional burnthrough-resistant insulation in the aircraft fuselage.

Abstract: Unique insulation articles including corrosion inhibitors and methods of producing the same are disclosed. One exemplary embodiment is an article of manufacture comprising an insulation mat comprising a cured combination of a plurality of randomly oriented fibers and a binder, the insulation mat extending between a first surface and a second surface, a veil attached to the first surface, the veil structured to inhibit physical movement of the cured combination through the veil, a metal sheet attached to the second surface by a water-containing adhesive contacting the metal sheet and the second surface, and a corrosion inhibitor composition deposited on the cured combination of the insulation mat, the corrosion inhibitor composition being effective to modify toward neutral a pH of the cured combination in contact with water from the water-containing adhesive.

Abstract: The present disclosure is directed to the use of certain glycosyltransferase variants having N-terminal truncation deletions. Contrary to previous findings certain truncations were found to exhibit sialidase enzymatic activity, particularly a variant of human sialyltransferase (hST6Gal-I) with a truncation deletion involving the first 89 N-terminal amino acids of the respective wild-type polypeptide. A fundamental finding documented in the present disclosure is that there exists a variant of this enzyme which is capable of catalyzing transfer of a glycosyl moiety as well as hydrolysis thereof. Thus, disclosed is a specific exemplary variant of mammalian glycosyltransferase, nucleic acids encoding the same, methods and means for recombinantly producing the variant of mammalian glycosyltransferase and use thereof, particularly for sialylating in a quantitatively controlled manner terminal acceptor groups of glycan moieties being part of glycoproteins such as immunoglobulins.

Abstract: Unique insulation articles including corrosion inhibitors and methods of producing the same are disclosed. One exemplary embodiment is an article of manufacture comprising an insulation mat comprising a cured combination of a plurality of randomly oriented fibers and a binder, the insulation mat extending between a first surface and a second surface, a veil attached to the first surface, the veil structured to inhibit physical movement of the cured combination through the veil, a metal sheet attached to the second surface by a water-containing adhesive contacting the metal sheet and the second surface, and a corrosion inhibitor composition deposited on the cured combination of the insulation mat, the corrosion inhibitor composition being effective to modify toward neutral a pH of the cured combination in contact with water from the water-containing adhesive.

Abstract: The present disclosure is directed to the use of certain glycosyltransferase variants having N-terminal truncation deletions. It was found that the combination of two different truncation variants of human ?-galactoside-?-2,6-sialyltransferase I (hST6Gal-I) exhibited different specific sialyltransferase enzymatic activities. In one example, under conditions wherein the first variant ?89 hST6Gal-I catalyzed formation of bi-sialylated target molecules the second variant ?108 hST6Gal-I catalyzed formation of mono-sialylated target molecules. Thus, disclosed are variants of mammalian glycosyltransferase, nucleic acids encoding the same, methods and means for recombinantly producing the variants of mammalian glycosyltransferase and use thereof, particularly for sialylating in a quantitatively controlled manner terminal acceptor groups of glycan moieties being part of glycoproteins such as immunoglobulins.

Abstract: Unique insulation articles including corrosion inhibitors and methods of producing the same are disclosed. One exemplary embodiment is an article of manufacture comprising an insulation mat comprising a cured combination of a plurality of randomly oriented fibers and a binder, the insulation mat extending between a first surface and a second surface, a veil attached to the first surface, the veil structured to inhibit physical movement of the cured combination through the veil, a metal sheet attached to the second surface by a water-containing adhesive contacting the metal sheet and the second surface, and a corrosion inhibitor composition deposited on the cured combination of the insulation mat, the corrosion inhibitor composition being effective to modify toward neutral a pH of the cured combination in contact with water from the water-containing adhesive.

Abstract: The present disclosure is directed to glycosyltransferase variants having N-terminal truncation deletions. Contrary to previous findings certain truncations comprising the conserved amino acid motif (“QVWxKDS”) were found to be compatible with glycosyltransferase enzymatic activity, particularly in a human sialyltransferase (hST6Gal-I). Thus, disclosed are variants of mammalian glycosyltransferase, nucleic acids encoding the same, methods and means for recombinantly producing the variants of mammalian glycosyltransferase and use thereof, particularly for sialylating terminal acceptor groups of glycan moieties being part of glycoproteins such as immunoglobulins.

Abstract: The present disclosure is directed to the use of certain glycosyltransferase variants having N-terminal truncation deletions. It was found that the combination of two different truncation variants of human ?-galactoside-?-2,6-sialyltransferase I (hST6Gal-I) exhibited different specific sialyltransferase enzymatic activities. In one example, under conditions wherein the first variant ?89 hST6Gal-I catalyzed formation of bi-sialylated target molecules the second variant ?108 hST6Gal-I catalyzed formation of mono-sialylated target molecules. Thus, disclosed are variants of mammalian glycosyltransferase, nucleic acids encoding the same, methods and means for recombinantly producing the variants of mammalian glycosyltransferase and use thereof, particularly for sialylating in a quantitatively controlled manner terminal acceptor groups of glycan moieties being part of glycoproteins such as immunoglobulins.